- Home
- RELX vs ORMP Comparison
RELX vs ORMP Comparison
Compare RELX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELX | ORMP |
|---|---|---|
| Founded | 1903 | 2002 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.3B | 104.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RELX | ORMP |
|---|---|---|
| Price | $40.87 | $3.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 272.5K |
| Earning Date | 07-24-2025 | 11-13-2025 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | 3.29 | ★ 838.25 |
| EPS | ★ 1.42 | 1.03 |
| Revenue | ★ $13,062,063,298.00 | $2,000,000.00 |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $6.60 | N/A |
| P/E Ratio | $28.51 | ★ $2.99 |
| Revenue Growth | ★ 2.48 | N/A |
| 52 Week Low | $39.31 | $1.82 |
| 52 Week High | $56.33 | $3.20 |
Technical Indicators
Market Signals| Indicator | RELX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 75.58 |
| Support Level | $39.40 | $2.66 |
| Resistance Level | $41.36 | $3.20 |
| Average True Range (ATR) | 0.36 | 0.13 |
| MACD | 0.30 | 0.03 |
| Stochastic Oscillator | 75.96 | 83.35 |
Price Performance
Historical ComparisonAbout RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.